London-Nadeau et al. urge solidarity against authoritarian attacks on bodily autonomy, highlighting shared histories of resistance and how they gesture to collective liberation.
The 60th Session of the Human Rights Council is an opportunity to bring attention to the impact of drug control policies on human rights worldwide, with the death penalty, violations of international humanitarian law, forced disappearances, and discussions on arbitrary detention taking place.
Ukraine has approved a new National Drug Policy strategy, which aims to improve access to controlled medicines, expand harm reduction programmes, and provide support to marginalized populations.
IDPC is seeking a consultant to help secure the future of the Support. Don't Punish campaign by diversifying its funding base and strengthening donor engagement.
Drawing on insights from over 200 partners, the campaign’s evaluation explores how Support. Don’t Punish has fostered the development of a global movement capable of shifting narratives, mobilising communities, and sparking change for rights-based, harm-reducing laws, policies and practices.
Mulcahy et al. explore whether stigma constitutes cruel, inhuman, and degrading treatment, outlining possibilities for viable legal claims on the basis of human rights.
For the 2025 Global Day of Action, thousands took action in 262 cities across 80 countries — demanding policies that ensure access to systems of care and support, not punishment.
Dr. Miller, Raychelle Baffo, and Andy O’Hara reveal how stigma harms people who use drugs, through hostile systems, housing barriers, and criminalization. These advocates urge action: raising awareness, challenge power, and demanding dignity in health, housing, and social services.
INPUD warns that abrupt US foreign aid cuts have devastated harm reduction services, leaving people who use drugs without life-saving care, triggering service collapse, job losses, and a looming human rights crisis.
IDPC calls on governments to end drug-related human rights abuses, invest in harm reduction, and align drug policies with human rights and protect the HIV response.
